India markets closed
BSE SENSEX
48,080.67+374.87(+0.79%)Nifty 50
14,406.15+109.75(+0.77%)Dow
34,030.79-106.52(-0.31%)
Novartis AG (NVS)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
88.32-0.34 (-0.38%)
As of 10:58AM EDT. Market open.
| Previous close | 88.66 |
| Open | 88.11 |
| Bid | 88.23 x 800 |
| Ask | 88.28 x 1300 |
| Day's range | 87.93 - 88.42 |
| 52-week range | 77.04 - 98.52 |
| Volume | 495,139 |
| Avg. volume | 2,024,393 |
| Market cap | 199.359B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 25.09 |
| EPS (TTM) | 3.52 |
| Earnings date | N/A |
| Forward dividend & yield | 3.20 (3.61%) |
| Ex-dividend date | 04-Mar-2021 |
| 1y target est | 104.67 |
- Zacks
Novartis (NVS) Collaborates with Roche for API of RA Drug Actemra
Novartis (NVS) enters into an agreement with Roche for the manufacturing of the active pharmaceutical ingredient (API) for Actemra/RoActemra.
- Zacks
Novartis (NVS) Teams Up With Artios for Radioligand Therapies
Novartis (NVS) enters a three-year collaboration with Artios to strengthen its radiogland therapies pipeline.
- Zacks
Novartis (NVS) Gets EC Nod For Kesimpta in Relapsing Forms of MS
The European Commission approves Novartis' (NVS) Kesimpta for the treatment of adult patients with relapsing forms of multiple sclerosis.
© 2021 Verizon Media. All rights reserved.
